Finance

Lists
VIR:NASDAQ
Vir Biotechnology Inc
10,71 $
+8,07%
(+0,80) 1D
10,71 $
0,00% (0,00)
After hours
Closed: 25 օգս, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VIR...
Open
10,03 $
High
11,28 $
Low
9,97 $
Mkt. cap
1,81 մլրդ
Avg. vol.
1,53 մլն
Volume
2,96 մլն
52-wk high
11,50 $
52-wk low
4,37 $
EPS
-1,86 $
Beta
1,66
Shares outstanding
169,22 մլն
No. of employees
367
Open
10,03 $
High
11,28 $
Low
9,97 $
Mkt. cap
1,81 մլրդ
Avg. vol.
1,53 մլն
Volume
2,96 մլն
52-wk high
11,50 $
52-wk low
4,37 $
EPS
-1,86 $
Beta
1,66
Shares outstanding
169,22 մլն
No. of employees
367
News stories
From web sources and news partners
About Vir Biotechnology Inc
CEOMarianne De Backer
Employees367
Founded07 ապր, 2016 թ.
HeadquartersՍան Ֆրանցիսկո, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitevir.bio
Analyst ratings
Based on 8 analysts giving stock ratings to VIR in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for VIR in the last 3 months.
Highest
Current 10,71 $
30,00 $ (+180,11%)
Average
21,29 $ (+98,79%)
Lowest
15,00 $ (+40,06%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
20,00 $
+86,7%
08/10/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
15,00 $
+40,1%
08/07/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
22,00 $
+105,4%
08/06/2026
Joseph Stringer
Needham
Buy
Reiterated
18,00 $
+68,1%
08/06/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
25,00 $
+133,4%
08/06/2026
Roanna Ruiz
Leerink Partners
Buy
Maintained
19,00 $
+77,4%
08/06/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/05/2026
Etzer Darout
Barclays
Buy
Maintained
30,00 $
+180,1%
08/06/2026
Paul Choi
Goldman Sachs
Buy
Maintained
21,00 $
+96,1%
05/06/2026
Sean McCutcheon
Raymond James
Buy
Maintained
19,00 $
+77,4%
02/24/2026
Last report
05 օգս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
0,47 $ / 0,72 $
-35,17%miss
Revenue / Est. (USD)
238,95 մլն / 222,57 մլն
+7,36%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
240,00 հզր
64,07 մլն
-29,00 հզր
238,95 մլն
Cost of goods sold
151,45 մլն
88,46 մլն
109,81 մլն
135,28 մլն
Cost of revenue
151,45 մլն
88,46 մլն
109,81 մլն
135,28 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,23 մլն
23,62 մլն
23,34 մլն
30,20 մլն
Operating expense
22,23 մլն
23,62 մլն
23,34 մլն
30,20 մլն
Total operating expenses
173,68 մլն
112,07 մլն
133,15 մլն
165,48 մլն
Operating income
-173,44 մլն
-48,00 մլն
-133,18 մլն
73,47 մլն
Other non operating income
-228,00 հզր
-335,00 հզր
-254,00 հզր
-451,00 հզր
EBT including unusual items
-162,97 մլն
-43,06 մլն
-125,52 մլն
80,26 մլն
EBT excluding unusual items
-164,31 մլն
-40,53 մլն
-126,24 մլն
81,98 մլն
Income tax expense
168,00 հզր
-137,00 հզր
170,00 հզր
179,00 հզր
Effective tax rate
-0,10%
0,32%
-0,14%
0,22%
Other operating expenses
-
-
-
-
Net income
-163,14 մլն
-42,92 մլն
-125,70 մլն
80,08 մլն
Net profit margin
-67 975,42%
-66,99%
433 431,03%
33,51%
Earnings per share
-1,17
-0,31
-0,85
0,47
Interest and investment income
9,36 մլն
7,80 մլն
7,19 մլն
8,97 մլն
Interest expense
-
-
-
-
Net interest expenses
9,36 մլն
7,80 մլն
7,19 մլն
8,97 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-170,44 մլն
-45,10 մլն
-130,37 մլն
76,27 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps